Navigation Links
AAPS immunogenicity training course to be offered prior to national biotechnology conference
Date:5/4/2010

WHO: The American Association of Pharmaceutical Scientists (AAPS) is a professional, scientific society of approximately 12,000 members employed in industry, academia, government and other research institutes worldwide. Founded in 1986, AAPS provides a dynamic international forum for the exchange of knowledge among scientists to enhance their contributions to public health. AAPS offers timely scientific programs, on-going education, information resources, opportunities for networking, and professional development.

WHAT: AAPS is pleased to present Development of Ligand Binding Analytical Methods to Support Immunogenicity Testing: Theoretical and Practical Considerations. The focus of this course is on the development and validation of analytical methods required for the detection and characterization of the anti-drug antibodies present in pre-clinical and clinical samples.

WHY: Attending this session will provide participants with familiarity of immune response as it is involved in the development of antibodies to biotherapeutic agents. Additional focus will be given to analytical methods used in detection, measurement, and characterization of the anti-drug antibody response, regulatory perspectives, and challenges in the area of immunogenicity.

WHEN/WHERE: May 15-16, 2010
Hilton San Francisco Union Square
San Francisco, CA


'/>"/>

Contact: Joseph Catapano
catapanoj@aaps.org
703-248-4772
American Association of Pharmaceutical Scientists
Source:Eurekalert

Page: 1

Related biology news :

1. Less is more when restraining calories boosts immunity
2. Rockefeller Foundation supports expansion, training of e-health work force in developing world
3. Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing
4. Concordia University to build innovative centre for health research and training
5. Stimulus-funded university research addressing issues from climate change to cancer, creating jobs and training a new generation of scientists
6. Building strong bones: Running may provide more benefits than resistance training, MU study finds
7. Biophysical sciences program receives $2 million training grant
8. Virtual reality: Keyhole surgeons training could help meet European working time directives
9. National and international doctoral training
10. NC State takes lead in crime scene investigation training
11. Researchers develop new self-training gene prediction program for fungi
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/2/2017)... JACKSONVILLE, Fla. , Feb. 2, 2017 /PRNewswire/ ... ), a clinical-stage immuno-oncology company specializing in the ... vaccines for the treatment of cancer and metastatic ... multi-gram scale-up and GMP manufacturing of a second ... T-cell vaccine targeting folate receptor alpha. The manufactured ...
(Date:2/2/2017)... , Feb. 1, 2017  Central to its ... meaningful advances worldwide, The Japan Prize Foundation today ... who have pushed the envelope in their respective ... Communication. Three scientists are being recognized with the ... that not only contribute to the advancement of ...
(Date:1/31/2017)... Jan. 31, 2017  Spero Therapeutics, LLC, a ... the treatment of bacterial infections, today announced it ... candidates from Pro Bono Bio Ltd (PBB) to ... multi-drug resistant forms of Gram-negative bacteria.   The assets ... Ltd, a PBB group company. "The ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... HACKENSACK, N.J. , Feb. 16, 2017  Champions ... engaged in the development and sale of advanced technology ... of oncology drugs, today announced the addition of new ... These new models will expand Champions, product ... cancer, head and neck cancer, AML, and non-small cell ...
(Date:2/16/2017)... and NEW YORK , Feb. 16, ... completion of their $7M Series B financing, adding an ... the $3.5M led by Mesa Verde Venture Partners and ... resources will be directed towards further accelerating commercial adoption ... comprehensive genomic profiling test and expanding the Paradigm cancer ...
(Date:2/15/2017)... , 15. Februar 2017  Trianni, Inc. ... Biotech, Inc. (Janssen) eine Lizenzvereinbarung über die Verwendung ... Klasse führenden Plattform für die Entdeckung monoklonaler Antikörper. ... ihr neuartiges chimäres Gensegmentdesign aus, das Janssen ... humanen Antikörpern bietet und das für die schelle ...
(Date:2/15/2017)... -- Windtree Therapeutics, Inc. (Nasdaq: WINT ), ... therapies for respiratory diseases, will host a conference call ... EST on Thursday, February 16, 2017 to provide updates ... announced closing of a $10.5 million private offering and ... in the live call and take part in the ...
Breaking Biology Technology: